For: | Alharbi OR, Azzam NA, Almalki AS, Almadi MA, Alswat KA, Sadaf N, Aljebreen AM. Clinical epidemiology of ulcerative colitis in Arabs based on the Montréal classification. World J Gastroenterol 2014; 20(46): 17525-17531 [PMID: PMC4265614 DOI: 10.3748/wjg.v20.i46.17525] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i46/17525.htm |
Number | Citing Articles |
1 |
Abdul Hakim Almakadma, Abdelkarim De Vol, Mohamad S. Alabdaljabar, Sarah Aldosari, Ibrahim Muhsen, Omar AlFreihi, Amr Kurdi, Majid Almadi, Fahad Alsohaibani. Complementary and alternative medicine use and its association with medication adherence in inflammatory bowel disease and other gastrointestinal diseases. Saudi Journal of Gastroenterology 2023; 29(4): 233 doi: 10.4103/sjg.sjg_468_22
|
2 |
Farzad Alinaghi, Hasan Göcker Tekin, Johan Burisch, Jashin J Wu, Jacob P Thyssen, Alexander Egeberg. Global Prevalence and Bidirectional Association Between Psoriasis and Inflammatory Bowel Disease—A Systematic Review and Meta-analysis. Journal of Crohn's and Colitis 2020; 14(3): 351 doi: 10.1093/ecco-jcc/jjz152
|
3 |
Mohammad S. Al-Zahrani, Ahmed A. Alhassani, Khalid H. Zawawi. Clinical manifestations of gastrointestinal diseases in the oral cavity. The Saudi Dental Journal 2021; 33(8): 835 doi: 10.1016/j.sdentj.2021.09.017
|
4 |
Zahra Momayez Sanat, Homayoon Vahedi, Reza Malekzadeh, Zeinab Fanni. Epidemiologic profile of inflammatory bowel disease in Eastern Mediterranean Region (EMRO) countries: a systematic review and meta-analysis. BMC Public Health 2024; 24(1) doi: 10.1186/s12889-024-18816-z
|
5 |
Misbahuddin Rafeeq, Hussam Aly Sayed Murad, Hossam Mohammed Abdallah, Ali M. El-Halawany. Protective effect of 6-paradol in acetic acid-induced ulcerative colitis in rats. BMC Complementary Medicine and Therapies 2021; 21(1) doi: 10.1186/s12906-021-03203-7
|
6 |
Othman Alharbi, Majid A. Almadi, Nahla Azzam, Abdulrahman M. Aljebreen, Turki AlAmeel, Stefan Schreiber, Mahmoud H. Mosli. Clinical characteristics, natural history, and outcomes of Crohn's-related intra-abdominal collections. Saudi Journal of Gastroenterology 2021; 27(2): 79 doi: 10.4103/sjg.SJG_89_20
|
7 |
Satimai Aniwan, Priscila Santiago, Edward V. Loftus, Sang Hyoung Park. The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries. United European Gastroenterology Journal 2022; 10(10): 1063 doi: 10.1002/ueg2.12350
|
8 |
Koroush Ghanadi, Javad Valizadeh, Afshin Hasanvand. Epidemiological and clinical aspects of ulcerative colitis in west of Iran: a cross sectional study. SpringerPlus 2016; 5(1) doi: 10.1186/s40064-016-3248-4
|
9 |
Nahla Azzam, Othman Alharbi, Mansour Altuwaijri, Yazed Alruthia, Heba Alfarhan, Suliman Alshankiti, Faris Nafisah, Qusay Ajlan, Abdulrahman Aljebreen, Majid Almadi, Mahmoud H. Mosli. The effectiveness of vedolizumab in advanced therapy-experienced ulcerative colitis patients: Real world data from the Inflammatory Bowel Disease of the Middle East (IBD-ME) Registry group. Saudi Journal of Gastroenterology 2025; 31(1): 34 doi: 10.4103/sjg.sjg_249_24
|
10 |
Naim Abu-Freha, Nour Ealiwa, Muhammad AbuTailakh, Muhammad Abu-Abed, Sarah Bader, Rachel Tabu, Doron Schwartz. Ethnic Issues and Disparities in Inflammatory Bowel Diseases: What Can We Learn from the Arab Population in Israel?. Journal of Personalized Medicine 2023; 13(6): 1008 doi: 10.3390/jpm13061008
|
11 |
Yachana Mishra, Vijay Mishra, Alaa A.A. Aljabali, Mohamed El-Tanani, Gowhar A. Naikoo, Nitin Charbe, Sai Raghuveer Chava, Murtaza M. Tambuwala. 3D Printed Personalized Colon-targeted Tablets: A Novel Approach in Ulcerative Colitis Management. Current Drug Delivery 2024; 21(9): 1211 doi: 10.2174/1567201821666230915150544
|
12 |
Mansour Altuwaijri, Loai Hakami, Othman Alharbi, Majid Almadi, Suliman Alshankiti, Abdulrahman Aljebreen, Nahla Azzam. The Long-Term Clinical Effectiveness of Ustekinumab in Antitumor Necrosis Factor-Experienced Crohn’s Disease Patients. Cureus 2022; doi: 10.7759/cureus.28536
|
13 |
Ala I Sharara, Samir Al Awadhi, Othman Alharbi, Hisham Al Dhahab, Mohamed Mounir, Leonardo Salese, Ena Singh, Nancy Sunna, Nadine Tarcha, Mahmoud Mosli. Epidemiology, disease burden, and treatment challenges of ulcerative colitis in Africa and the Middle East. Expert Review of Gastroenterology & Hepatology 2018; 12(9): 883 doi: 10.1080/17474124.2018.1503052
|
14 |
Nahla A. Azzam, Abdulelah Almutairdi, Hajer Y. Almudaiheem, Turki AlAmeel, Shakir A. Bakkari, Othman R. Alharbi, Khalidah A. Alenzi, Maha A. AlMolaiki, Bedor A. Al-Omari, Rayan G. Albarakati, Ahmed H. Al-Jedai, Omar I. Saadah, Majid A. Almadi, Badr Al-Bawardy, Mahmoud H. Mosli. Saudi consensus guidance for the management of inflammatory bowel disease during pregnancy. Saudi Journal of Gastroenterology 2023; doi: 10.4103/sjg.sjg_318_23
|
15 |
Zahra Momayez Sanat, Homayoon Vahedi, Reza Malekzadeh, Zeinab Fanni. A systematic review and meta-analysis of extra-intestinal manifestation of inflammatory bowel disease in the Eastern Mediterranean Region (EMRO) countries. Annals of Medicine & Surgery 2024; 86(5): 2892 doi: 10.1097/MS9.0000000000001543
|
16 |
Jesús K. Yamamoto-Furusho, Andrea Sarmiento-Aguilar. Joint involvement in Mexican patients with ulcerative colitis: a hospital-based retrospective study. Clinical Rheumatology 2018; 37(3): 677 doi: 10.1007/s10067-017-3834-z
|
17 |
Othman AlHarbi, Niazy Abu Farsakh, Sameer Al-Awadhi, Talal Al-Taweel, Inas Mikhail, Faisal Batwa, Khalil Bedran, Dilara Balkan, Levent Mert Gunay, Joseph C. Cappelleri, Marco Boeri, Colton Leach, Sara Habjoka, Mahmoud Mosli. Patient Preferences for Ulcerative Colitis Treatment in the Middle East Region: A Discrete-Choice Experiment. Gastro Hep Advances 2024; 3(2): 190 doi: 10.1016/j.gastha.2023.10.002
|
18 |
Mohammed Hammoudeh, Eman Elsayed, Saad Al-Kaabi, Manik Sharma, Mohamed Elbadri, Prem Chandra, Niveen Abu Nahia, Samer Hammoudeh. Rheumatic manifestations of inflammatory bowel diseases: A study from the Middle East. Journal of International Medical Research 2018; 46(9): 3837 doi: 10.1177/0300060518781404
|
19 |
Othman R. AlHarbi, Ahmad Bahammam, Awad H. Olaish, Nahla A. Azzam, Abdulrahman A. Aljebreen, Majid A. Almadi, Suhail A. Alsaleh. Prevalence, severity and associated factors of restless leg syndrome in inflammatory bowel disease patients. Saudi Journal of Gastroenterology 2021; 27(6): 348 doi: 10.4103/sjg.sjg_642_20
|
20 |
Ibrahim Masoodi, Ali S. Alshanqeeti, Shameem Ahmad, Essam J. Alyamani, Abed A. Al-Lehibi, Adel N. Qutub, Khalid N. Alsayari, Ahmed O. Alomair. Microbial dysbiosis in inflammatory bowel diseases: results of a metagenomic study in Saudi Arabia. Minerva Gastroenterologica e Dietologica 2019; 65(3) doi: 10.23736/S1121-421X.19.02576-5
|
21 |
Yazed AlRuthia, Othman Alharbi, Abdulrahman M. Aljebreen, Nahla A. Azzam, Majid A. Almadi, Ohud H. Bahari, Khalid A. Almalki, Abdulaziz T. Atham, Ahmed S. Alanazi, Maria Saeed, Baraa HajkhderMullaissa, Mohammad Alsenaidy, Bander Balkhi. Drug utilization and cost associated with inflammatory bowel disease management in Saudi Arabia. Cost Effectiveness and Resource Allocation 2019; 17(1) doi: 10.1186/s12962-019-0194-3
|
22 |
Othman Alharbi, Abdulrahman M. Aljebreen, Nahla A. Azzam, Majid A. Almadi, Maria Saeed, Baraa HajkhderMullaissa, Hassan Asiri, Abdullah Almutairi, Yazed AlRuthia. Predictors of Anti-TNF Therapy Failure among Inflammatory Bowel Disease (IBD) Patients in Saudi Arabia: A Single-Center Study. Journal of Clinical Medicine 2022; 11(14): 4157 doi: 10.3390/jcm11144157
|
23 |
Mahmoud Mosli, Sameer Alawadhi, Fuad Hasan, Antoine Abou Rached, Faisal Sanai, Silvio Danese. Incidence, Prevalence, and Clinical Epidemiology of Inflammatory Bowel Disease in the Arab World: A Systematic Review and Meta-Analysis. Inflammatory Intestinal Diseases 2021; 6(3): 123 doi: 10.1159/000518003
|